OncoLink
Oncolink Cancer Resources OncoLink Cancer Resources
OncoLink Cancer Resources
OncoLink
Friday, February 10, 2012 Close Window
OncoLink
OncoLink OncoLink
OncoLink

Chemotherapy-Induced Anemia in Cancer Patients - Post Test

Name:
Street Address:
City:     State/Province:
Country:   ZIP/Postal Code:
Telephone #: Email:
I am a Registered Nurse
Please email me when more CME becomes available.
Please add me to the Oncolink Newsletter

  1. The European Cancer Anaemia Survey reported that 25% of patients who received chemotherapy demonstrated anemia (hemoglobin< 12.0 g/dL).
    1. True
    2. False
  2. Patients who received platinum compounds have double the risk of developing anemia as those who receive other chemotherapy agents.
    1. True
    2. False
  3. Risk factors for anemia include:
    1. Combination therapy with radiation and chemotherapy
    2. History of drug abuse
    3. Low baseline hemoglobin
    4. A & C
  4. Signs and symptoms of anemia include all except:
    1. Tachypnea
    2. Dyspnea on exertion
    3. Nausea
    4. Orthostasis
  5. Differential diagnosis of anemia in the cancer patient can include:
    1. Bleeding
    2. Nutritional deficiency
    3. Renal failure
    4. Viral or bacterial infections
    5. All of the above
  6. Transfusion of packed red blood cells:
    1. Provides urgent treatment of anemia.
    2. Is often used to treat a hemoglobin <9g/dl or in a symptomatic patient.
    3. Is an effective treatment for a patient with thrombocytopenia.
    4. A & B
  7. Erythropoietin is an endogenous hormone, which is involved in the maturation, proliferation, and differentiation of red blood cells.
    1. True
    2. False
  8. Erythropoietic stimulating agents:
    1. Should only be used to treat anemia while a patient is receiving myelosuppressive chemotherapy.
    2. Should be withheld when the hemoglobin level exceeds 12 g/dl.
    3. Were found to shorten the overall survival and time to tumor progression in clinical trials, which included patients with various tumor types.
    4. All of the above
  9. In one study, intravenous iron, given in conjunction with an ESA,:
    1. Reduced the number of RBC transfusions needed.
    2. Increased the risk of bleeding.
    3. Led to a more rapid response to ESA therapy.
    4. A & C
  10. Patient education for the patient with CIA should include:
    1. Energy conservation techniques to cope with fatigue.
    2. Information about increasing dietary iron intake.
    3. The importance of exercise in coping with fatigue.
    4. All of the above

Please hit submit only once. The results may take a few minutes to load on slower connections.

OncoLink

Trustees of the University of Pennsylvania